申请人:Pharmacopeia, Inc.
公开号:US05688997A1
公开(公告)日:1997-11-18
Combinatorial libraries are disclosed which are represented by Formula I: (T'-L).sub.q -S-C(O)-L'-II' I wherein: S is a solid support; T'-L- is an identifier residue; and -L'-II' is a ligand/linker residue. These libraries contain dihydrobenzopyrans of the formula: ##STR1## which interact (i.e., as agonists or antagonists) with .alpha. adrenergic receptors, dopamine receptors, .sigma.-opiate receptors, and K.sup.+ channels and are inhibitors of carbonic anhydrase isozymes. They are useful in the treatment of ocular diseases such as glaucoma.
揭示了由公式I表示的组合库:(T'-L).sub.q -S-C(O)-L'-II'I,其中:S是固体支撑体;T'-L-是标识残基;-L'-II'是配体/连接体残基。这些库包含公式为:##STR1## 的二氢苯并吡喃,与α肾上腺能受体、多巴胺受体、σ-阿片受体和K.sup.+通道相互作用(即作为激动剂或拮抗剂),并且是碳酸酐酶同工酶的抑制剂。它们在治疗青光眼等眼部疾病方面很有用。